In 2023, the turnover of biotechnology research and experimental development in Germany stood at 3.16 billion Euros. The sector has shown significant volatility over the years, with peaks and troughs in growth rates. Notably, there was a sharp increase of 49% in 2018, followed by a significant downward adjustment of -27.78% in 2019. In the most recent period, the year-on-year growth for 2023 was 4.73%, reflecting a steady but less aggressive growth trend compared to earlier years.
Over the last two years, from 2022 to 2023, the sector experienced stable growth but at a modest pace. The Compound Annual Growth Rate (CAGR) over the last five years was 0.63%, indicating an overall tempered steady increase.
For future trends, the forecasted growth from 2024 to 2028 shows an expected continuation of this steady increase, with a projected 5-year CAGR of 3.09%. The sector is predicted to grow by 16.45% over this period. Key trends to watch include advancements in biotechnological innovations, increased investment in research and development, and potential regulatory changes affecting the industry.
